These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 12532093)
1. Why must olympic athletes prove that they have asthma to be permitted to take inhaled beta2-agonists? Weiler JM J Allergy Clin Immunol; 2003 Jan; 111(1):36-7. PubMed ID: 12532093 [No Abstract] [Full Text] [Related]
2. Diagnosis of asthma and permitted use of inhaled beta2-agonists in athletes. Bonini S; Brusasco V; Carlsen KH; Delgado L; Del Giacco SR; Haahtela T; Rasi G; van Cauwenberge PB Allergy; 2004 Jan; 59(1):33-6. PubMed ID: 14674930 [No Abstract] [Full Text] [Related]
3. Asthma medication in Finnish olympic athletes: no signs of inhaled beta2-agonist overuse. Alaranta A; Alaranta H; Palmu P; Alha P; Pietilä K; Heliövaara M; Helenius I Med Sci Sports Exerc; 2004 Jun; 36(6):919-24. PubMed ID: 15179158 [TBL] [Abstract][Full Text] [Related]
4. Inhaled beta2 agonists and performance in competitive athletes. Kindermann W; Meyer T Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i43-7. PubMed ID: 16799103 [TBL] [Abstract][Full Text] [Related]
5. The asthmatic athlete: inhaled Beta-2 agonists, sport performance, and doping. McKenzie DC; Fitch KD Clin J Sport Med; 2011 Jan; 21(1):46-50. PubMed ID: 21200170 [TBL] [Abstract][Full Text] [Related]
7. Bronchial challenges in athletes applying to inhale a beta2-agonist at the 2004 Summer Olympics. Anderson SD; Sue-Chu M; Perry CP; Gratziou C; Kippelen P; McKenzie DC; Beck KC; Fitch KD J Allergy Clin Immunol; 2006 Apr; 117(4):767-73. PubMed ID: 16630932 [TBL] [Abstract][Full Text] [Related]
8. Inappropriate use of inhaled beta agonists in asthma. Burgess C; Crane J; Pearce N; Beasley R N Z Med J; 1990 Jul; 103(894):353-4. PubMed ID: 1973826 [No Abstract] [Full Text] [Related]
9. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes? Kindermann W Sports Med; 2007; 37(2):95-102. PubMed ID: 17241101 [TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical treatment of asthma symptoms in elite athletes - doping or therapy? Backer V; Lund T; Pedersen L Scand J Med Sci Sports; 2007 Dec; 17(6):615-22. PubMed ID: 18093034 [TBL] [Abstract][Full Text] [Related]
11. Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment. Bergés R; Segura J; Ventura R; Fitch KD; Morton AR; Farré M; Mas M; de La Torre X Clin Chem; 2000 Sep; 46(9):1365-75. PubMed ID: 10973867 [TBL] [Abstract][Full Text] [Related]
13. Regular inhaled beta-adrenergic agonists in the treatment of bronchial asthma: beneficial or detrimental? Nelson HS; Szefler SJ; Martin RJ Am Rev Respir Dis; 1991 Aug; 144(2):249-50. PubMed ID: 1677552 [No Abstract] [Full Text] [Related]
18. [Measurement of peak inspiratory flow with asthma: effect of inhaled beta2-stimulant]. Shimizu K; Yamazaki Y; Kishimoto N; Tada S; Ueda N; Fujita J; Kamei T; Okada H; Arakawa Y; Nakamura H Nihon Kokyuki Gakkai Zasshi; 2005 Apr; 43(4):216-20. PubMed ID: 15966367 [TBL] [Abstract][Full Text] [Related]
19. Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children. Plotnick LH; Ducharme FM Cochrane Database Syst Rev; 2000; (4):CD000060. PubMed ID: 11034671 [TBL] [Abstract][Full Text] [Related]
20. The role of inhaled long-acting beta-2 agonists in the management of asthma. Kelly HW; Harkins MS; Boushey H J Natl Med Assoc; 2006 Jan; 98(1):8-16. PubMed ID: 16532973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]